The LDN Research Trust was founded by a group of patients with Multiple Sclerosis, for whom LDN worked very well after all other treatments had failed. The primary aim of the Trust is to initiate Clinical Trials of Low Dose Naltrexone.

Whilst working to raise funds for trials, we have helped over 19,000 people  to obtain LDN from a General Practitioner or Neurologist, either through the National Health Service or by private prescription.  We have also been able to help people, not just in the UK but in countries throughout Europe, as well as USA, Canada, West Indies, Australia, New Zealand, and others. On this website and from our downloadable newsletters, you will be able to read the stories of some of these people.

The aim objective is to promote research for the benefit of the public by the promotion and funding of research and clinical trials of Low Dose Naltrexone (LDN) as a treatment for Multiple Sclerosis and the publication of such research.